Cargando…
Bilateral visual outcomes and service utilization of patients treated for 3 years with ranibizumab for neovascular age-related macular degeneration
BACKGROUND: The aim of this study was to describe bilateral visual outcomes and the effect of incomplete follow-up after 3 years of ranibizumab therapy for neovascular age-related macular degeneration. Secondarily, the demands on service provision over a 3-year period were described. METHODS: Data o...
Autores principales: | Chavan, Randhir, Panneerselvam, Swati, Adhana, Parul, Narendran, Nirodhini, Yang, Yit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986417/ https://www.ncbi.nlm.nih.gov/pubmed/24748766 http://dx.doi.org/10.2147/OPTH.S60763 |
Ejemplares similares
-
Ranibizumab in neovascular age-related macular degeneration
por: Eng, Kenneth T, et al.
Publicado: (2006) -
Real-World Visual And Clinical Outcomes For Patients With Neovascular Age-Related Macular Degeneration Treated With Intravitreal Ranibizumab: An 8-Year Observational Cohort (AMD8)
por: Horner, Faye, et al.
Publicado: (2019) -
A Case of Candida albicans Endophthalmitis with No Predisposing Risk Factors and a Distant Source of Infection
por: Chavan, Randhir, et al.
Publicado: (2012) -
Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration
por: Hurley, Susan F, et al.
Publicado: (2008) -
Resource Use and Real-World Outcomes for Ranibizumab Treat and Extend for Neovascular Age-Related Macular Degeneration in the UK: Interim Results from TERRA
por: Yang, Yit, et al.
Publicado: (2017)